Copyright
©The Author(s) 2023.
World J Stem Cells. Apr 26, 2023; 15(4): 221-234
Published online Apr 26, 2023. doi: 10.4252/wjsc.v15.i4.221
Published online Apr 26, 2023. doi: 10.4252/wjsc.v15.i4.221
Figure 1 Immune pathways in graft-versus-host disease and sites where therapy is used to block graft-versus-host disease development (red bars).
APC: Antigen-presenting cell; ATG: Antithymocyte globulin; CSA: Cyclosporine A; DAMPs; Damage-associated molecular patterns; Foxp3+: Forkhead box P3; GCs: Glucocorticosteroids; GVHD: Graft-versus-host disease; MSC: Mesenchymal stem cell; TNF: Tumor necrosis factor; NK: Natural killer cells; PAMPs: Pathogen-associated molecular patterns.
- Citation: Jaing TH, Chang TY, Chiu CC. Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease. World J Stem Cells 2023; 15(4): 221-234
- URL: https://www.wjgnet.com/1948-0210/full/v15/i4/221.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v15.i4.221